Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal

Delcourt C, Le Goff M, von Hanno T, Mirshahi A, Khawaja AP, Verhoeven VJM, et al. The decreasing prevalence of nonrefractive visual impairment in older Europeans: a meta-analysis of published and unpublished data. Ophthalmology. 2018;125(8):1149–59.

PubMed  Article  Google Scholar 

Ramos PL, Santana R, Marques AP, Sousa I, Rocha-Sousa A, Macedo AF. Prevalence and causes of vision impairment in Norwest Portugal: a capture and recapture study. medRxiv; 2021.

Centers for Disease Control and Prevention. 2021. Available from: https://www.cdc.gov/visionhealth/vehss/data/studies/vision-impairment-and-blindness.html.

Man REK, Gan ATL, Fenwick EK, Gupta P, Thakur S, Fang XL, et al. The differential impact of age on vision-related quality of life across the visual impairment spectrum. Ophthalmology. 2021;128(3):354–63.

PubMed  Article  Google Scholar 

Crews JE, Chou C-F, Zack MM, Zhang X, Bullard KM, Morse AR, et al. The association of health-related quality of life with severity of visual impairment among people aged 40–64 years: findings from the 2006–2010 behavioral risk factor surveillance system. Ophthalmic Epidemiol. 2016;23(3):145–53.

PubMed  PubMed Central  Article  Google Scholar 

Nickels S, Schuster AK, Elflein H, Wolfram C, Schulz A, Münzel T, et al. Vision-related quality of life considering both eyes: results from the German population-based Gutenberg Health Study (GHS). Health Qual Life Outcomes. 2019;17(1):98.

PubMed  PubMed Central  Article  Google Scholar 

Schliermann R, Heydenreich P, Bungter T, Anneken V. Health-related quality of life in working-age adults with visual impairments in Germany. Disabil Rehabil. 2017;39(5):428–37.

PubMed  Article  Google Scholar 

Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119(7):1050–8.

CAS  PubMed  Article  Google Scholar 

Taipale J, Mikhailova A, Ojamo M, Nättinen J, Väätäinen S, Gissler M, et al. Low vision status and declining vision decrease health-related quality of life: results from a nationwide 11-year follow-up study. Qual Life Res. 2019;28(12):3225–36.

PubMed  PubMed Central  Article  Google Scholar 

Tseng YC, Liu SH, Lou MF, Huang GS. Quality of life in older adults with sensory impairments: a systematic review. Qual Life Res. 2018;27(8):1957–71.

PubMed  Article  Google Scholar 

World Health Organization. World Health Organization Access 2022. Available from: https://www.who.int/tools/whoqol.

Taylor DJ, Hobby AE, Binns AM, Crabb DP. How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open. 2016;6(12): e011504.

PubMed  PubMed Central  Article  Google Scholar 

Park SJ, Ahn S, Woo SJ, Park KH. Extent of exacerbation of chronic health conditions by visual impairment in terms of health-related quality of life. JAMA Ophthalmol. 2015;133(11):1267–75.

PubMed  Article  Google Scholar 

De Sousa Peixoto R, Krstic L, Hill SCL, Foss AJE. Predicting quality of life in AMD patients-insights on the new NICE classification and on a bolt-on vision dimension for the EQ-5D. Eye (Lond). 2021.

Purola PKM, Nättinen JE, Ojamo MUI, Koskinen SVP, Rissanen HA, Sainio PRJ, et al. Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment. Qual Life Res. 2021;30(8):2311–27.

PubMed  PubMed Central  Article  Google Scholar 

Longworth L, Yang Y, Young T, Mulhern B, Alava MH, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess 2014;18(9).

Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. 2015;33(11):1137–54.

PubMed  PubMed Central  Article  Google Scholar 

Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012;15(1):118–27.

PubMed  PubMed Central  Article  Google Scholar 

Langelaan M, de Boer MR, van Nispen RM, Wouters B, Moll AC, van Rens GH. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol. 2007;14(3):119–26.

PubMed  Article  Google Scholar 

Devlin N, Parkin D, Janssen B. An Introduction to EQ-5D instruments and their applications. Methods for analysing and reporting EQ-5D data. Cham: Springer; 2020. p. 1–22.

Google Scholar 

EuroQol Research Foundation 2021. EuroQol Research Foundation. EQ-5D-3L User Guide. Available from: Available online: https://euroqol.org/publications/user-guides/.

Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21(1):587–611.

CAS  PubMed  Article  Google Scholar 

Aspinall PA, Johnson ZK, Azuara-Blanco A, Montarzino A, Brice R, Vickers A. Evaluation of quality of life and priorities of patients with glaucoma. Investig Ophthalmol Vis Sci. 2008;49(5):1907–15.

Article  Google Scholar 

Choi S, Choi JA, Kwon JW, Park SM, Jee D. Utility values for glaucoma patients in Korea. PLoS ONE. 2018;13(5): e0197581.

PubMed  PubMed Central  Article  CAS  Google Scholar 

King AJ, Fernie G, Azuara-Blanco A, Burr JM, Garway-Heath T, Sparrow JM, et al. Treatment of advanced glaucoma study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma—study protocol. Br J Ophthalmol. 2018;102(7):922–8.

PubMed  Article  Google Scholar 

Hernández-Moreno L, Senra H, Lewis P, Moreno N, Linhares J, Santana R, et al. Cost-effectiveness of basic vision rehabilitation (The basic VRS-effect study): study protocol for a randomised controlled trial. Ophthalmic Physiol Opt. 2020;40(3):350–64.

PubMed  Article  Google Scholar 

Malkin AG, Goldstein JE, Perlmutter MS, Massof RW. Responsiveness of the EQ-5D to the effects of low vision rehabilitation. Optom Vis Sci. 2013;90(8):799–805.

PubMed  PubMed Central  Article  Google Scholar 

Malkin AG, Goldstein JE, Massof RW. Multivariable regression model of the EuroQol 5-dimension questionnaire in patients seeking outpatient low vision rehabilitation. Ophthalmic Epidemiol. 2017;24(3):174–80.

PubMed  PubMed Central  Article  Google Scholar 

Chatzirallis A, Varaklioti A, Sergentanis TN, Theodossiadis P, Chatziralli I. Quality of life among patients with retinal vein occlusion: a case-control study. Semin Ophthalmol. 2021:1–7.

Heintz E, Wiréhn AB, Peebo BB, Rosenqvist U, Levin L. QALY weights for diabetic retinopathy—a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health. 2012;15(3):475–84.

PubMed  Article  Google Scholar 

Bozzani FM, Alavi Y, Jofre-Bonet M, Kuper H. A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma. BMC Ophthalmol. 2012;12:43.

PubMed  PubMed Central  Article  Google Scholar 

Lloyd A, Schofield H, Adlard N. Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued? Curr Med Res Opin. 2020;36(4):609–11.

PubMed  Article  Google Scholar 

Brazier J. Is the EQ–5D fit for purpose in mental health? Br J Psychiatry. 2010;197(5):348–9.

PubMed  Article  Google Scholar 

Rand K, Arnevik EA, Walderhaug E. Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L. J Patient Rep Outcomes. 2020;4(1):92.

PubMed  PubMed Central  Article  Google Scholar 

Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9).

Kay S, Ferreira A. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol. 2014;21(2):66–78.

PubMed  Article  Google Scholar 

Payakachat N, Summers KH, Pleil AM, Murawski MM, Thomas J 3rd, Jennings K, et al. Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Qual Life Res. 2009;18(7):801–13.

PubMed  Article  Google Scholar 

Huygens SA, Versteegh MM, Vegter S, Schouten LJ, Kanters TA. Methodological challenges in the economic evaluation of a gene therapy for RPE65-mediated inherited retinal disease: the value of vision. Pharmacoeconomics. 2021;39(4):383–97.

PubMed  PubMed Central  Article  Google Scholar 

Jayasundera KT, Abuzaitoun RO, Lacy GD, Abalem MF, Saltzman GM, Ciulla TA, et al. Challenges of cost-effectiveness analyses of novel therapeutics for Inherited Retinal Diseases: cost-effectiveness analysis in Inherited Retinal Diseases. Am J Ophthalmol. 2021.

Ramos PL, Santana R, Moreno LH, Marques AP, Freitas C, Rocha-Sousa A, et al. Predicting participation of people with impaired vision in epidemiological studies. BMC Ophthalmol. 2018;18(1):236.

PubMed  PubMed Central  Article  Google Scholar 

Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91–6.

PubMed  Article  Google Scholar 

Vanden Bosch ME, Wall M. Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method. Eye. 1997;11(3):411–7.

PubMed  Article  Google Scholar 

Ferreira LN, Ferreira PL, Pereira LN, Oppe M. The valuation of the EQ-5D in Portugal. Qual Life Res. 2014;23(2):413–23.

PubMed  Article  Google Scholar 

Massof RW, Hsu CT, Baker FH, Barnett GD, Park WL, Deremeik JT, et al. Visual disability variables. I: the importance and difficulty of activity goals for a sample of low-vision patients. Arch Phys Med Rehabil. 2005;86(5):946–53.

PubMed  Article  Google Scholar 

Massof RW, Hsu CT, Baker FH, Barnett GD, Park WL, Deremeik JT, et al. Visual disability variables. II: The difficulty of tasks for a sample of low-vision patients. Arch Phys Med Rehabil. 2005;86(5):954–67.

PubMed  Article  Google Scholar 

Goldstein JE, Chun MW, Fletcher DC, Deremeik JT, Massof RW, Low Vision Research Network Study G. Visual ability of patients seeking outpatient low vision services in the United States. JAMA Ophthalmol. 2014;132(10):1169–77.

PubMed  PubMed Central  Article  Google Scholar 

Hernández-Moreno L, Massof RW, S

留言 (0)

沒有登入
gif